Daiichi Sankyo: Hit On Multiple Fronts, But Shares Look Undervalued
Source: SeekingAlpha
2026-02-24 05:00:00 ET
The last year has not been a good one for Japanese pharma company Daiichi Sankyo ( DSNKY ) ( DSKYF ) (4568.T). From earnings misses to worries about clinical efficacy and safety to questions about corporate strategy, it’s been a period where investors have hammered the shares on bad news (real or perceived) while giving little credit for positive developments....
Read the full article on Seeking Alpha
For further details see:
Daiichi Sankyo: Hit On Multiple Fronts, But Shares Look Undervalued
Daiichi Sankyo Co Ltd Sponsored ADR Level 1
NASDAQ: DSNKY
DSNKY Trading
-3.5% G/L:
$17.67 Last:
40,774 Volume:
$17.60 Open:
DSNKY Latest News
January 21, 2026 08:00:00 am
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
